Karyopharm Therap
KPTI1.92072.61% ( -5.090 )
Karyopharm Therap (KPTI)
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the t...
- Open
- 2.190
- High
- 2.430
- Low
- 1.800
- Prev. Close
- 7.010
- Volume
- 22.40M
- Turnover
- 45.77M
- Avg Price
- 2.043
- Bid/Ask Ratio
- --
- Amplitude
- 8.99%
- 52wk High
- 10.990
- Volume Ratio
- 28.18
- Turnover Ratio
- 151.22%
Karyopharm Therap Analyst Rating
View MoreForecast & Rating
Jul 31, 2026Price forecast
$6.40233.33%
Forecast & RatingBuy
6analysts
- Strong buy33.33%
- Buy33.33%
- Hold33.33%
- Sell0.00%
- Strong sell0.00%
News
- Global Report · 20 hours ago
The 2026 Biotech Reckoning: Enough With the AI Hype, Show Me the Efficacy
- benzinga_article · 2 days ago, 12:05 PM
12 Health Care Stocks Moving In Friday's Intraday Session
- benzinga_article · 2 days ago, 11:02 AM
Crude Oil Gains 1%; Apple Shares Tumble After Q3 Results
- benzinga_article · 2 days ago, 07:15 AM
Amazon To Rally Around 55%? Here Are 10 Top Analyst Forecasts For Friday
- benzinga_article · 2 days ago, 07:05 AM
12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga_article · 2 days ago, 06:20 AM
This Edison International Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
